June 30, 2010
Response Genetics' ResponseDX: Lung
Full-text access for premium subscribers only.
Existing premium subscribers
New to GenomeWeb?
Focusing on Personalized Medicine, Pfizer Reports PGx Data for Several Oncologics at ASCO
June 9, 2010 / Pharmacogenomics Reporter
Two ASCO Studies Show Challenge of Using MET Signaling as Predictive Marker in NSCLC Drug Trials
June 11, 2014 / Pharmacogenomics Reporter
Case Study Suggests FISH Test May Miss Some Patients Who Could Benefit from Crizotinib
September 12, 2012 / Pharmacogenomics Reporter
Patient Enrichment to Limit PGx Testing for NSCLC Could Lower Costs, but Miss Responders
March 21, 2012 / Pharmacogenomics Reporter
German Team Debuts ALK Testing Method Similar to Pfizer Team's but with Potential for Broader Appeal
March 5, 2014 / Pharmacogenomics Reporter